Our data, in conjunction with findings from previous studies25,26,36,37,46, indicate that CAR T-cells with a CD28 CSD exhibit rapid expansion and increased anti-tumor activity but are linked to shorter persistence and a greater tendency for T-cell exhaustion compared to those with a 4-1BB CSD. This evidence concerns the gene CD28 and neoplasm.